TA - GAP GAP GAP, page-29

Hi @Raffout. Reply not working so here we go! My interpretation of DT and RFKs past stance was one of freedom of choice and verified safety. DTs stance on fluoride is along the same lines. Past issue appears to be the en-masse (enforced) use of vaccines with a special disfavor for any medications or vaccine that lack adequate historical safety and efficacy studies. For science and for IMU I interpret the appointment of RFK as posing no negative issues. IMUs immediate issue is - as everyone knows, is that it is IP Asset rich and Cash-Flow poor. IMUs IP is too far advanced and will survive however no matter the immediate future. For the FDA though if you or your department were not performing or were perceived as a wasted of resources I would be worried. He will have a plan no doubt for the FDA and it I suspect that it won’t include free loading bureaucratic red tape wielding passengers. This is good for the bio-tech industry. My opinion only of course!